Crossref
Amyloid Antagonists: The Future of Type 2 Diabetes as well as Several Neurodegenerative Diseases Treatments
Diabetes & Obesity International Journal · 2018
DOI: 10.23880/doij-16000106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes & Obesity International Journal, 2018. Verfasst von Kelleni MT.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
MT, K. (2018). Amyloid Antagonists: The Future of Type 2 Diabetes as well as Several Neurodegenerative Diseases Treatments. Diabetes & Obesity International Journal. https://doi.org/10.23880/doij-16000106
Vancouver
MT K. Amyloid Antagonists: The Future of Type 2 Diabetes as well as Several Neurodegenerative Diseases Treatments. Diabetes & Obesity International Journal. 2018. doi:10.23880/doij-16000106
BibTeX
@article{MT2018,
author = {MT, Kelleni},
title = {Amyloid Antagonists: The Future of Type 2 Diabetes as well as Several Neurodegenerative Diseases Treatments},
journal = {Diabetes & Obesity International Journal},
year = {2018},
doi = {10.23880/doij-16000106}
}
EUVIMED